CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 -3.0  -1.2%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3274th / 3891

TABLE-CellSeed - 9-MTH group results

Thu 14th November, 2019 7:00am
Nov 14 (Reuters)- 
             CellSeed Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2019        Sep 30, 2018      Dec 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            210 mln             543 mln           300 mln    
                 (-61.2 pct)                           (+29.2 pct)  
  Operating     loss 554 mln         loss 94 mln        loss 1.10   
  Recurring     loss 558 mln         loss 94 mln        loss 1.10   
  Net           loss 557 mln         loss 96 mln        loss 1.10   
  EPS          loss 48.55 yen       loss 8.43 yen    loss 95.99 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - CellSeed Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.